ATG10 overexpression enhances the proliferation of endometrial cancer (HEC-1-A), hepatocellular carcinoma (Hep3B and PLC), nasopharyngeal carcinoma (HONE-1, CNE-2 and 5-8F), colorectal cancer (SW480, SW620 and DLD-1), gastric cancer (SGC-7901, MGC-803, GIST-882, GIST-T1, AGS and HGC27) and lung cancer (A549 and H1299) cells. This evidence concerns the gene ATG10 and nasopharyngeal carcinoma.